Title |
Bioactive C17-Polyacetylenes in Carrots (Daucus carota L.): Current Knowledge and Future Perspectives
|
---|---|
Published in |
Journal of Agricultural & Food Chemistry, October 2015
|
DOI | 10.1021/acs.jafc.5b04357 |
Pubmed ID | |
Authors |
Corinna Dawid, Frank Dunemann, Wilfried Schwab, Thomas Nothnagel, Thomas Hofmann |
Abstract |
C17-polyacetylenes are a prominent group of oxylipins and are primarily produced by plants of the families Apiaceae, Araliaceae, and Asteraceae, respectively. Recent studies on the biological activity of PAs have indicated their potential to improve human health due to anticancer, antifungal, antibacterial, anti-inflammatory, and serotogenic effects. These findings suggest targeting vegetables with elevated levels of bisacetylenic oxylipins, such as, e.g. falcarinol by breeding studies. Due to the abundant availability, high diversity of cultivars, world-wide experience and its high agricultural yields, in particular, carrot (Daucus carota L.) genotypes are a very promising target vegetable. This article provides a review on falcarinol-type C17-polyacetylenes in carrots and a perspective on their potential as a future contributor to improving human health and well-being. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 1% |
Unknown | 78 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 16 | 20% |
Student > Ph. D. Student | 15 | 19% |
Researcher | 8 | 10% |
Student > Doctoral Student | 4 | 5% |
Student > Bachelor | 4 | 5% |
Other | 11 | 14% |
Unknown | 21 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 18 | 23% |
Chemistry | 10 | 13% |
Biochemistry, Genetics and Molecular Biology | 7 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
Medicine and Dentistry | 3 | 4% |
Other | 9 | 11% |
Unknown | 27 | 34% |